[1] Hallett MA, Venmar KT, Fingleton B.Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13[J]. Cancer Research, 2012, 72(24): 6338-6343. [2] Suzuki A, Leland P, Joshi BH, et al.Targeting of IL-4 and IL-13 receptors for cancer therapy[J]. Cytokine, 2015, 75(1): 79-88. [3] Wang HW, Joyce JA.Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions[J]. Cell Cycle, 2010, 9(24): 4824-4835. [4] Platzbecker U, Ehninger G, Bornhäuser M.Allogeneic transplantation of CD34+ selected hematopoietic cells-clinical problems and current challenges[J]. Leukemia & Lymphoma, 2004, 45(3): 447-453. [5] Kapoor S, Shenoy SP, Bose B.CD34 cells in somatic, regenerative and cancer stem cells: Developmental biology, cell therapy, and omics big data perspective[J]. Journal of Cellular Biochemistry, 2020, 121: 3058-3069. [6] 吕家兴,白磊鹏,金宇. 兔VX2骨肿瘤模型研究进展[J]. 肿瘤预防与治疗,2020,33(2):184-189. [7] 黄权,杨兴海,肖建如,等. 兔VX2瘤脊柱转移动物模型的实验研究[J]. 脊柱外科杂志,2011,9(2):117-120. [8] Fujimiya K, Sugihara K, Nishikawa T.Experimental study on the role of osteoclasts and free radicals in the mandibular invasion of VX2 carcinoma in Japanese white rabbits[J]. Bone, 1997, 20(3): 245-250. [9] Marx V.Tracking metastasis and tricking cancer[J]. Nature, 2013, 494(7435): 133-136. [10] Takahashi M, Komine K, Imai H, et al.Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis[J]. PLoS One, 2017, 12(5): e0176972. [11] Hamaji M, Chen F, Miyamoto E, et al.Surgical and non-surgical management of repeat pulmonary metastasis from sarcoma following first pulmonary metastasectomy[J]. Surgery Today, 2016, 46(11): 1296-1300. [12] Harwood JL, Alexander JH, Mayerson JL, et al.Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma[J]. The Orthopedic Clinics of North America, 2015, 46(4): 587-608. [13] Versleijen-Jonkers YM, Vlenterie M, van de Luijtgaarden AC, et al. Anti-angiogenic therapy, a new player in the field of sarcoma treatment[J]. Critical Reviews in Oncology/Hematology, 2014, 91(2): 172-185. [14] Ueno M, Lo CW, Barati D, et al.Interleukin-4 overexpressing mesenchymal stem cells within gelatin-based microribbon hydrogels enhance bone healing in a murine long bone critical-size defect model[J]. J Biomed Mater Res A, 2020, 108(11): 2240-2250. [15] Little AC, Pathanjeli P, Wu Z, et al.IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling[J]. Frontiers in Oncology, 2019, 9: 456. [16] Ando K.Human CD34- hematopoietic stem cells: basic features and clinical relevance[J]. International Journal of Hematology, 2002, 75(4): 370-375. [17] Barth PJ, Westhoff CC.CD34+ fibrocytes: morphology, histogenesis and function[J]. Current Stem cell Research & Therapy, 2007, 2(3): 221-227. [18] 曹海营,冯震,赵景新,等. 一次性密封栓封堵骨孔制作兔骨肿瘤模型实验研究[J]. 中华实用诊断与治疗杂志,2016,30(6):563-565. |